Skip to main content
Equibles

BARCLAYS PLC

Position in ALEC — Alector, Inc.

CIK 312069 LONDON, X0
Back to ALEC Full portfolio

Position in ALEC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$90,363
-$1,207 QoQ
Shares Held
44,957
+5.6% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALEC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. ALEC ranks #252 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in ALEC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $90,363 44,957
2026-03-31 $91,570 42,591
2025-12-31 $621,951 398,687
2025-09-30 $2,585,189 873,375
2025-06-30 $237,713 169,795
2025-03-31 $153,855 125,086
2024-12-31 $333,715 176,569
2024-09-30 $823,888 176,800
2024-06-30 $345,353 76,069
2024-03-31 $615,394 102,225
2023-12-31 $1,541,959 193,228
2023-09-30 $899,592 138,826
2023-06-30 $672,939 111,970
2023-03-31 $787,956 127,295
2022-12-31 $1,280,579 138,741
2022-09-30 $1,481,511 156,608
2022-06-30 $196,087 19,300
2022-03-31 $264,522 18,563
2021-12-31 $2,269,868 109,921
2021-09-30 $1,674,873 73,395
2021-06-30 $1,191,745 57,213
2021-03-31 $2,016,415 100,120
2020-12-31 $493,237 32,600
2020-09-30 $416,817 39,565
2020-06-30 $1,634,693 66,886
2020-03-31 $1,087,345 45,062